JP2013515002A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515002A5
JP2013515002A5 JP2012544917A JP2012544917A JP2013515002A5 JP 2013515002 A5 JP2013515002 A5 JP 2013515002A5 JP 2012544917 A JP2012544917 A JP 2012544917A JP 2012544917 A JP2012544917 A JP 2012544917A JP 2013515002 A5 JP2013515002 A5 JP 2013515002A5
Authority
JP
Japan
Prior art keywords
composition
dimethylamino
composition according
ketoprofen
dodecyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012544917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013515002A (ja
JP6200648B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/061130 external-priority patent/WO2011075688A1/en
Publication of JP2013515002A publication Critical patent/JP2013515002A/ja
Publication of JP2013515002A5 publication Critical patent/JP2013515002A5/ja
Application granted granted Critical
Publication of JP6200648B2 publication Critical patent/JP6200648B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012544917A 2009-12-18 2010-12-17 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物 Expired - Fee Related JP6200648B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28795309P 2009-12-18 2009-12-18
US61/287,953 2009-12-18
PCT/US2010/061130 WO2011075688A1 (en) 2009-12-18 2010-12-17 Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016028621A Division JP2016155817A (ja) 2009-12-18 2016-02-18 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2013515002A JP2013515002A (ja) 2013-05-02
JP2013515002A5 true JP2013515002A5 (OSRAM) 2017-07-20
JP6200648B2 JP6200648B2 (ja) 2017-09-20

Family

ID=44167727

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012544917A Expired - Fee Related JP6200648B2 (ja) 2009-12-18 2010-12-17 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物
JP2016028621A Pending JP2016155817A (ja) 2009-12-18 2016-02-18 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016028621A Pending JP2016155817A (ja) 2009-12-18 2016-02-18 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための方法および組成物

Country Status (9)

Country Link
US (2) US20130109674A1 (OSRAM)
EP (1) EP2512240B1 (OSRAM)
JP (2) JP6200648B2 (OSRAM)
AU (2) AU2010330747B2 (OSRAM)
CA (1) CA2784824A1 (OSRAM)
DK (1) DK2512240T3 (OSRAM)
ES (1) ES2677352T3 (OSRAM)
IL (2) IL220464A (OSRAM)
WO (1) WO2011075688A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010330750B2 (en) 2009-12-18 2015-10-01 Exodos Life Sciences Limited Partnership Methods and compositions for stable liquid drug formulations
US9192637B1 (en) * 2011-09-23 2015-11-24 Natural Fibers Corporation Milkweed seed oil administered to animals
WO2013074517A1 (en) * 2011-11-14 2013-05-23 Roswell Park Cancer Institute Kinase protein binding inhibitors
US8822537B2 (en) * 2012-09-27 2014-09-02 Achelios Therapeutics, Inc. Topical ketoprofen composition
WO2014074744A1 (en) * 2012-11-09 2014-05-15 Lasser Elliott C X-ray contrast media compositions and methods of using the same to treat inflammation associated conditions
WO2014138748A1 (en) * 2013-03-08 2014-09-12 Research Institute At Nationwide Children's Hospital Transcutaneous dosage formulation
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US9011934B2 (en) 2013-06-14 2015-04-21 SatisPharma, LLC Multi-purpose anti-itch treatment
JP2017503604A (ja) 2014-01-22 2017-02-02 マーシオ マーク アブリュー Ａｂｒｅｕ脳熱トンネルでの治療を提供するように構成されたデバイス
US9452178B1 (en) 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations
JP2017536421A (ja) * 2014-12-01 2017-12-07 アケリオス セラピューティクス，インコーポレーテッド 片頭痛及び疼痛に関連する状態を処置するための方法及び組成物
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
BR112017020307B1 (pt) 2015-03-26 2023-11-07 Jacqueline M. Iversen Usos de uma combinação de naproxeno e fexofenadina
WO2017024214A1 (en) * 2015-08-05 2017-02-09 Synergistic Therapeutics, Llc Topical analgesis loton
US20190105260A1 (en) * 2016-03-22 2019-04-11 The Regents Of The University Of California Compositions and methods to promote wound healing
JP7024248B2 (ja) * 2016-09-01 2022-02-24 大正製薬株式会社 固形製剤
US10624867B2 (en) 2017-05-15 2020-04-21 Biochemics, Inc. Transdermally-delivered combination drug therapy for pain
JP7673337B2 (ja) * 2019-11-07 2025-05-09 アリナミン製薬株式会社 医薬組成物
EP3900715A1 (en) * 2020-04-21 2021-10-27 Dompe' Farmaceutici S.P.A. Synergistic admixtures of gabapentin and ketoprofen, pharmaceutical compositions and their medical use
EP3900716A1 (en) * 2020-04-21 2021-10-27 Dompe' Farmaceutici S.P.A. Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical use
WO2023073457A1 (en) * 2021-10-30 2023-05-04 Mousavi Mirzaei Seyed Mohammad A topical pain-relief medicine for relieving headache

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5169637A (en) 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
CA1237671A (en) 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
US5409704A (en) 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
US4975282A (en) 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
US5023087A (en) 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
IE60901B1 (en) 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5032582A (en) 1987-02-27 1991-07-16 Liposome Technology, Inc. Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
US4994213A (en) 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
US5082866A (en) 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5194266A (en) 1989-08-08 1993-03-16 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition and method
US5356633A (en) 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
DK0580817T3 (da) 1991-04-19 1996-08-05 Nexstar Pharmaceuticals Inc Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
GR1002207B (en) 1992-08-06 1996-03-27 Johnson & Johnson Consumer Skin care compositions containing imidazoles.
US5552155A (en) 1992-12-04 1996-09-03 The Liposome Company, Inc. Fusogenic lipsomes and methods for making and using same
AU5938996A (en) 1995-06-07 1996-12-30 Nexstar Pharmaceuticals, Inc. Method for encapsulating pharmaceutical materials
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6387407B1 (en) * 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
CN1102852C (zh) * 1995-11-13 2003-03-12 皮特迈国际有限公司 含一氧化二氮的止痛药、消炎药和解热药的给药介质及含有这样的介质和药物的药物组合物
US6083996A (en) 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6139861A (en) * 1999-01-14 2000-10-31 Friedman; Mark Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm
US6118020A (en) * 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6642243B1 (en) * 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
US20020143047A1 (en) * 2001-01-05 2002-10-03 Galer Bradley S. Methods for treating indomethacin responsive headaches
US20070112052A9 (en) 2001-01-05 2007-05-17 Larry Caldwell Methods and compositions for treating headache pain with topical NSAID compositions
EP1435945B1 (en) * 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
US20040138239A1 (en) * 2001-08-23 2004-07-15 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
WO2003077847A2 (en) * 2002-03-12 2003-09-25 Merck & Co., Inc. Substituted amides
US20060178354A1 (en) * 2003-02-27 2006-08-10 Lucas John M Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
US7357950B2 (en) * 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
US20050095277A1 (en) * 2003-06-25 2005-05-05 Binnur Ozturk Neuropathy cream
US20050019354A1 (en) * 2003-07-23 2005-01-27 Perricone Nicholas V. Topical benfotiamine treatments
JP2007519756A (ja) * 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
AU2005235309B2 (en) * 2004-04-19 2012-07-26 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US7749515B2 (en) * 2005-02-01 2010-07-06 Allergan, Inc. Targeted delivery of botulinum toxin to the sphenopalatine ganglion
US20090214466A1 (en) * 2005-05-09 2009-08-27 Levin Bruce H Methods of Alleviating Disorders and Their Associated Pain
US20070054843A1 (en) * 2005-08-26 2007-03-08 Yeomans David C Methods for treatment of headaches by administration of oxytocin
WO2007061694A2 (en) * 2005-11-18 2007-05-31 Merck & Co., Inc. Spirohydantoin tricyclic cgrp receptor antagonists
US20090312435A1 (en) * 2006-08-30 2009-12-17 Auspex Pharmaceuticals, Inc Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Similar Documents

Publication Publication Date Title
JP2013515002A5 (OSRAM)
US12296011B2 (en) Methods for photodynamic therapy
JP6434104B2 (ja) ジクロフェナク製剤
ES2714550T3 (es) Composiciones farmacéuticas y método para tratar la inflamación en ganado bovino y otros animales
JP2000143540A (ja) 非ステロイド系消炎鎮痛薬含有外用剤
KR20150071027A (ko) 수의학적 소음 혐오증 완화 방법
ES2624557T3 (es) Composiciones farmacéuticas transdérmicas que comprenden un SERM
CN101530401A (zh) 一种用于治疗急慢性炎性疼痛的复方透皮贴片
MXPA04007214A (es) Formulaciones topicas que contienen farmacos antiinflamatorios no esteroidales que demuestran actividad quimiopreventiva.
JP5828609B2 (ja) 持続性解熱鎮痛消炎剤
CA2583876A1 (en) A transmucosal veterinary composition comprising detomidine
ES2533854T3 (es) Composiciones farmacéuticas transdérmicas que comprenden danazol
WO2014163030A1 (ja) 馬の炎症治療のための製剤
US20130197089A1 (en) Compositions for the treatment of actinic keratosis
US20130190715A1 (en) Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis
JP2003119119A (ja) 肛門用の皮膚外用剤
US11642328B2 (en) Creatine, its derivatives, compositions and methods of use thereof
ES2963708T3 (es) Bromhexina para el tratamiento del dolor
JPS6127920A (ja) 消炎鎮痛性外用医薬組成物
JP2005089345A (ja) 虫刺され治療薬
KR20030027100A (ko) 화상의 치료
TR2024002454A1 (tr) Topical compositions comprising nimesulide and diclofenac sodium and a salicylate
JP2012067057A (ja) ピタバスタチン及びセルレニンを含有する経皮吸収促進剤
JP2023553300A (ja) フルニキシンを口腔投与することによる疼痛の治療方法
JP2012067055A (ja) セルレニンを含有する経皮吸収促進剤